Salesforce stock steadies premarket after 7% drop as AI worries shadow Slackbot rollout

Salesforce stock was steady near $241 in U.S. premarket trading Wednesday, following a steep drop the day before. The cloud software company closed Tuesday down 7.07% at $241.06, with shares swinging between $260.91 and $240.35 on roughly 13.7 million shares traded.

Qiniu stock jumps after AI user count tops 180,000 as investors chase smaller tech names

Qiniu stock jumps after AI user count tops 180,000 as investors chase smaller tech names

Shares of Hong Kong-listed Qiniu jumped more than 7% in intraday trade on Tuesday and were last up 5.97% at HK$0.71, with turnover of HK$1.4 million, after the company disclosed its model-as-a-service, or MaaS, user count had topped 180,000, Zhituo Finance reported. Qiniu has been bundling open- and closed-source AI models including DeepSeek and MiniMax on its MaaS platform, betting it can shift revenue away from basic bandwidth and storage toward higher-value inference API calls, the report said. It pointed to a run of AI catalysts — including talk of a DeepSeek V4 release and a ByteDance AI tie-up around the Lunar New Year gala — and cited Guojin Securities as calling 2026 a turning point for AI applications, with Huajin Securities noting AI is already cutting costs in businesses such as content and marketing.
IBM stock drops 3% as Confluent deal clears key U.S. antitrust step ahead of Jan. 28 earnings

IBM stock drops 3% as Confluent deal clears key U.S. antitrust step ahead of Jan. 28 earnings

Confluent confirmed that the U.S. antitrust waiting period for International Business Machines’ $11 billion acquisition has lapsed, marking a key regulatory milestone. The Hart-Scott-Rodino Act’s waiting period expired at 11:59 p.m. ET on Jan. 12. IBM shares closed Tuesday down 2.9% at $303.16. Confluent also announced a shareholder meeting scheduled for Feb. 12 but noted that additional regulatory approvals remain pending.
Thermo Fisher stock falls as CEO flags new U.S. reshoring contracts, Nvidia tie-up in focus

Thermo Fisher stock falls as CEO flags new U.S. reshoring contracts, Nvidia tie-up in focus

Thermo Fisher Scientific’s pharmaceutical services unit has secured contracts to assist clients shifting drug manufacturing from Europe or Asia back to the U.S., CEO Marc Casper revealed Tuesday. Shares slipped 1.4% to close at $607.08. Casper highlighted a strong push toward reshoring production and operations to the U.S., calling it a boost for 2027 and 2028 as a proposed 100% tariff on imported medicines looms.
1 173 174 175 176 177 305

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Kodiak Gas Services

NYSE:KGS • Energy infrastructure 88/100 • ★★★★☆
#2 STRONG BUY

Neurocrine Biosciences

NASDAQ:NBIX • Healthcare 87/100 • ★★★★☆
#3 STRONG BUY

Alphabet Class A

NASDAQ:GOOGL • Communication services 85/100 • ★★★★☆
#4 BUY ON WEAKNESS

Applied Materials

NASDAQ:AMAT • Semiconductor equipment 84/100 • ★★★★☆
#5 ACCUMULATE

JPMorgan Chase

NYSE:JPM • Financials 80/100 • ★★★★☆
View full portfolio
Editorial model selection. Not personalised advice.